Oosthuizen J, Kotze MJ, Van Der Merwe N, Myburgh EJ, Bester P, van der Merwe NC. Globally Rare BRCA2 Variants With Founder Haplotypes in the South African Population: Implications for Point-of-Care Testing Based on a Single-Institution BRCA1/2 Next-Generation Sequencing Study. Front Oncol. 2020;10:619469.
Globally Rare BRCA2 Variants With Founder Haplotypes in the South African Population: Implications for Point-of-Care Testing Based on a Single-Institution BRCA1/2 Next-Generation Sequencing Study
By Content Specialist|2022-07-05T09:49:01+02:00July 5, 2022|2021: January to March|Comments Off on Globally Rare BRCA2 Variants With Founder Haplotypes in the South African Population: Implications for Point-of-Care Testing Based on a Single-Institution BRCA1/2 Next-Generation Sequencing Study
Share This Story, Choose Your Platform!
About the Author: Content Specialist
Related Posts
Corrigendum to “Paclitaxel alleviates the sepsis-induced acute kidney injury via lnc-MALAT1/miR-370-3p/HMGB1 axis” [Life Sci. 2020 Dec 1; 262:118505. doi:10.1016/j.lfs.2020.118505. Epub 2020 Sep 28].